Peyronie’s disease can be distressing and isolating. It may cause a new bend in the penis during erection, pain, a feeling of shortening, and sometimes difficulty getting or keeping an erection. Stem cell based treatments are being explored as a regenerative approach, particularly for men in the earlier, active phase of the condition, with the aim of reducing inflammation and supporting tissue healing.

Understanding Peyronie’s disease and what treatment is trying to achieve

Peyronie’s disease is linked to the development of fibrous scar tissue (often called plaque) within the erectile tissue. This can reduce the normal elasticity of the penis, leading to curvature, indentation, or narrowing during erection. Some men also experience pain, and erectile dysfunction can occur if blood flow or the mechanics of erection are affected.

Treatment goals depend on the stage and impact of the condition. In general, care focuses on:

• Reducing pain in the active phase
• Limiting progression of curvature
• Preserving sexual function and erection quality
• Addressing distress and relationship impact

In established, stable Peyronie’s disease, the plaque and curvature may be less likely to change, and different treatments may be more appropriate.

What stem cell treatment is in this context

Stem cells are cells with regenerative potential. In medicine, “stem cell treatment” can refer to different biological therapies, and it is important to be clear about what is being offered and what evidence exists.

For Peyronie’s disease, stem cell based approaches are intended to support tissue repair and help calm inflammatory processes that may contribute to plaque development. These treatments are not the same as standard, guideline-based options such as collagenase injections (where available), traction therapy, or surgery. They are best understood as an emerging regenerative strategy that may be considered in selected cases.

Commonly discussed regenerative options

Depending on local regulation and clinical protocols, regenerative treatments may include:

• Platelet-rich plasma (PRP): derived from a blood sample and concentrated platelets. PRP is not a stem cell treatment, but it is sometimes grouped with regenerative therapies.
• Stromal vascular fraction (SVF): a cell mixture obtained from processed fat tissue that can include stem and progenitor cells.
• Laboratory-expanded stem cell preparations (often described as GMP-grade): cells prepared under strict quality-controlled manufacturing standards. Preparation may take time because cells are processed and checked before use.

Not every option is suitable or available for every patient, and the regulatory framework can affect what can be offered.

Who may be suitable, and when it may not be the right choice

Stem cell based treatment may be considered for men who:

• Have bothersome symptoms in the active phase (typically when pain or change in curvature is still occurring)
• Have early erectile difficulties linked to Peyronie’s disease
• Want a non-surgical approach and understand the limits of current evidence

It may be less suitable when:

• The condition has been stable for a prolonged period and the main issue is a fixed curvature that prevents intercourse
• There is severe curvature, complex deformity (such as significant hourglass narrowing), or major loss of length where established interventions may be more effective
• There is untreated infection, a bleeding disorder, or other medical factors that increase procedure risk
• Expectations are for guaranteed straightening or full reversal of long-standing plaque, which cannot be promised

A careful assessment is essential because Peyronie’s disease varies greatly between individuals.

Assessment and planning at our clinic

A thorough andrological and urological assessment helps confirm the diagnosis, identify the disease phase, and clarify the main treatment goal.

Your consultation typically includes:

• A detailed history of symptoms, pain, progression, and sexual function
• Review of medications and relevant medical conditions (for example diabetes, cardiovascular disease, testosterone status where appropriate)
• Physical examination to assess plaque location and penile shape changes
• Discussion of erection quality and whether erectile dysfunction is present
• Imaging when needed, commonly penile ultrasound (sometimes with an induced erection) to assess plaque characteristics and blood flow

This planning stage is also where realistic outcomes are discussed. Some men prioritise pain relief and preserving function, while others are mainly concerned about curvature and penetrative sex.

How the treatment is generally carried out

The exact protocol depends on the type of regenerative therapy used.

In broad terms:

• The procedure is performed as an outpatient treatment.
• Local anaesthetic is typically used to keep discomfort to a minimum.
• The prepared biological material is injected into targeted areas, which may include the plaque and/or erectile tissue, depending on the clinical plan.

If a laboratory-prepared stem cell product is used, there is usually a preparation period before the treatment date. This can take days to weeks depending on the method and regulatory requirements.

Combination approaches

In selected patients, regenerative injections may be combined with other non-surgical measures such as:

• Penile traction therapy to support length and shape over time
• Low-intensity shockwave therapy in specific protocols
• Medical management of erectile dysfunction (for example PDE5 inhibitors) when appropriate

Combination treatment is not automatically necessary, but it can be considered when the goal is to support both tissue health and functional outcomes.

Recovery and what to expect afterwards

Most men return home the same day.

Common short-term effects can include:

• Mild bruising, swelling, or tenderness at injection sites
• Temporary discomfort during erections

Patients are usually advised to:

• Avoid sexual activity for a short period after treatment (timing is individual and will be confirmed in your aftercare plan)
• Follow hygiene and activity guidance to reduce infection risk
• Attend follow-up to monitor symptoms and progression

When results may be noticed

Peyronie’s disease often changes slowly, and regenerative treatments are not an instant fix. If improvement occurs, it may be gradual over weeks to months. Follow-up focuses on:

• Pain levels
• Changes in curvature or deformity
• Erectile function and sexual confidence
• Whether additional treatment sessions or supportive therapies are appropriate

Risks, limitations, and important considerations

All procedures have potential risks. For injection-based regenerative treatments, these may include:

• Bruising, swelling, pain, or small lumps at injection sites
• Infection (uncommon but important)
• Bleeding or haematoma, particularly in men on blood thinners
• Temporary worsening of discomfort

Limitations are equally important:

• Evidence for stem cell based treatment in Peyronie’s disease is still developing. Outcomes can vary, and long-term comparative data against established treatments may be limited.
• Existing, long-standing plaque and fixed curvature may not fully resolve.
• No treatment can reliably predict or guarantee the final curvature angle.

For men whose main problem is a stable curvature that prevents intercourse, established options such as traction, intralesional therapies, or surgery may offer more predictable correction. These alternatives should be discussed as part of balanced decision-making.

Your consultation pathway and ongoing support

Care for Peyronie’s disease is rarely a single-step journey. Our medical team focuses on continuity, clear communication, and a plan that fits your symptoms and priorities.

From the first appointment, you can expect:

• A structured assessment to confirm diagnosis and disease phase
• A personalised discussion of options, including non-procedural and surgical alternatives where appropriate
• Clear explanation of what is realistic to achieve and what is not
• Follow-up to track progress and adjust the plan if symptoms change

If you are considering stem cell based treatment, the consultation is the right time to discuss the specific preparation method, expected timelines, the number of sessions that may be advised, and how outcomes will be monitored. The aim is to help you make an informed decision with support from a specialist team that understands both the physical and emotional impact of Peyronie’s disease.